Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.sanjivani.co.in | |
Market Cap | 135.28 Cr. | |
Enterprise Value(EV) | 138.66 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 5.20 | Trailing Twelve Months Ending 2023-09 |
Price-Earning Ratio (PE) | 26.00 | Trailing Twelve Months Ending 2023-09 |
Industry PE | 38.59 | Trailing Twelve Months Ending 2023-09 |
Book Value / Share | 0.18 | Trailing Twelve Months Ending 2023-09 |
Price to Book Value | 735.73 | Calculated using Price: 135.30 |
Dividend Yield | 0.00 | Period Ending 2023-03 |
No. of Shares Subscribed | 1.00 Cr. | 9,998,300 Shares |
FaceValue | 10 | |
About Sanjivani Paranteral Ltd. | ||
Sanjivani Parenteral was established in 1997 by A H Khemka, Ashwin Khemka and Somesh Khemka, under the technical direction of Mahendra Kalwankar. It is a research-based, international pharmaceutical company that provides a wide range of high quality products and services at affordable prices. The core product range of the company's products includes oral solids, small volume parenterals and sterile powder formulations. |
1 Day |
|
-1.99% |
1 Week |
|
-1.99% |
1 Month |
|
+6.45% |
3 Month |
|
+43.88% |
6 Month |
|
+89.61% |
1 Year |
|
+238.97% |
2 Year |
|
+383.04% |
5 Year |
|
+3198.78% |
10 Year |
|
+1036.55% |
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | -7.19 | -58.98 | -596.93 | |||||||
Return on Capital Employed (%) | 5.69 | -7.28 | -33.04 | -227.28 | -265.98 | 266.43 | ||||
Return on Assets (%) | -2.09 | -14.16 | -34.18 | -124.34 | -9.62 | -10.16 | 8.13 | 25.80 | 22.96 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 32 | 18 | -9 | -53 | -47 | -49 | -45 | -8 | -3 | 0 | |
Non Curr. Liab. | 7 | 14 | 9 | 6 | 10 | 9 | 7 | 4 | 1 | 1 | |
Curr. Liab. | 75 | 62 | 61 | 72 | 56 | 55 | 58 | 22 | 23 | 23 | |
Minority Int. | |||||||||||
Equity & Liab. | 114 | 93 | 60 | 25 | 18 | 16 | 19 | 18 | 21 | 24 | |
Non Curr. Assets | 16 | 23 | 17 | 16 | 11 | 12 | 10 | 11 | 13 | 11 | |
Curr. Assets | 98 | 70 | 43 | 9 | 7 | 4 | 9 | 8 | 8 | 14 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 114 | 93 | 60 | 25 | 18 | 16 | 19 | 18 | 21 | 24 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09 Rs. Cr. TTM |
Net Sales | 133 | 115 | 33 | 18 | 25 | 16 | 25 | 31 | 35 | 44 | |
Other Income | 1 | 1 | 3 | 0 | 1 | 0 | 0 | 2 | 1 | 0 | |
Total Income | 135 | 116 | 36 | 18 | 26 | 17 | 25 | 32 | 36 | 44 | |
Total Expenditure | -128 | -121 | -56 | -70 | -27 | -17 | -23 | -26 | -30 | -37 | |
PBIDT | 7 | -5 | -20 | -52 | -1 | 0 | 2 | 6 | 6 | 7 | |
Interest | -8 | -9 | -5 | 0 | 0 | -1 | 0 | 0 | 0 | 0 | |
Depreciation | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | |
Taxation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | |
Exceptional Items | 0 | ||||||||||
PAT | -2 | -15 | -26 | -53 | -2 | -2 | 1 | 5 | 5 | 5 | |
Adjusted EPS | -4 | -25 | -44 | -90 | -4 | -3 | 2 | 5 | 5 | 5 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 9 | -1 | 0 | 10 | 3 | 2 | 0 | 1 | 9 | 5 | |
Cash Fr. Inv. | -1 | 9 | -1 | 0 | 0 | 0 | 0 | 0 | -1 | -1 | |
Cash Fr. Finan. | -8 | -7 | -1 | -10 | -3 | -2 | 0 | 0 | -8 | -4 | |
Net Change | 0 | 0 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Cash & Cash Eqvt | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Wed, 22 Nov 2023
Announcement under Regulation 30 (LODR)-Investor Presentation Revised Investor Presentation of Sanjivani Paranteral Limited highlighting the performance of the Company during the quarter and Half Year ended on September 30 2023 |
Fri, 17 Nov 2023
Announcement under Regulation 30 (LODR)-Investor Presentation Revised Investor Presentation of Sanjivani Paranteral Limited highlighting the performance of the Company during the quarter and half year ended on September 30 2023. |
Wed, 25 Oct 2023
Announcement under Regulation 30 (LODR)-Earnings Call Transcript Transcript of Earnings Call with the Investors and Analysists conducted on October 19 2023 for the second quarter ended September 30 2023. |
Wed, 06 Dec 2023 |
|
|
|
|
|